İbrutinib Sonrası Gelişen Dev Ekimoz ve Hematom: Olgu Sunumu
Kronik lenfositik lösemi ve Mantle hücreli lenfoma da yeni bir tedavi seçeneği olan ibrutinib, yüksek etkinliği ile günümüzde sık kullanılmaya başlanmıştır. Hedefe yönelik monoklonal antikorların yan etkileri sitotoksik tedavilere göre daha hafif seviyede görülmektedir. İbrutinibin de ishal, bitkinl...
Saved in:
Main Authors: | Aynur Uğur Bilgin, Özcan Çeneli, Handan Çipil, Sinan Demircioğlu |
---|---|
Format: | Article |
Language: | English |
Published: |
Selcuk University Press
2017-03-01
|
Series: | Genel Tıp Dergisi |
Subjects: | |
Online Access: | https://dergipark.org.tr/tr/download/article-file/2156683 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Ibrutinib associated cardiovascular events in a patient wearing an implanted loop recorder
by: Daniel Rivera, et al.
Published: (2021-06-01) -
Ibrutinib-associated osteonecrosis of the jaw
by: Annu Singh, et al.
Published: (2024-03-01) -
BCR SIGNALING INHIBITORS: AN OVERVIEW OF TOXICITIES ASSOCIATED WITH IBRUTINIB AND IDELALISIB IN PATIENTS WITH CHRONIC LYMPHOCYTIC LEUKEMIA
by: Lorenzo Falchi, et al.
Published: (2016-02-01) -
The infectious thyroid nodule: a case report of mucormycosis associated with ibrutinib therapy
by: Marco A. Mascarella, et al.
Published: (2019-10-01) -
Ibrutinib disrupts blood-tumor barrier integrity and prolongs survival in rodent glioma model
by: Sanghee Lim, et al.
Published: (2024-04-01)